LUPIN vs WOCKPHARMA: Stock Comparison

Lupin Limited vs Wockhardt Ltd

Live data: 22 July 2026, 3:04 PM IST • Source: NSE and company filings

Lupin Limited is the larger company by market capitalisation. Lupin Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Lupin Limited and Wockhardt Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, LUPIN is more favourable on 12 of 13 scored metrics and WOCKPHARMA on 1These counts are context-free and are not an overall rating.

Key Differences

Market Cap

LUPIN is the larger company

₹1.1 L Cr vs ₹30,362 Cr

P/E Ratio

LUPIN has a lower P/E

21.56x vs 144.46x

P/B Ratio

LUPIN has a lower P/B

5.12x vs 6.23x

EPS

LUPIN has higher earnings per share

₹116.56 vs ₹13.1

Dividend Yield

LUPIN has a higher dividend yield

0.48% vs 0%

Revenue Growth (TTM YoY)

LUPIN has faster revenue growth

31.9% vs 26%

EPS Growth (TTM YoY)

LUPIN has faster EPS growth

89% vs 0%

Qtr Sales Growth

LUPIN has stronger quarterly sales growth

31.9% vs 29.9%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

Metric	LUPIN	WOCKPHARMA
Sector	Healthcare	Healthcare
Industry	Pharmaceuticals	Pharmaceuticals

Price

Metric	LUPIN	WOCKPHARMA
Live Price	₹2,408.8	₹1,864
Day Change	-4.22%	-1.7%
Volume	10.51 L	7.24 L
52-Week High	₹2,529.5	₹2,422.3
52-Week Low	₹1,836.8	₹1,086.7
Distance from 52W High	-4.77%	-23.05%

Valuation

Metric	LUPIN	WOCKPHARMA
Market Cap	₹1.1 L Cr	₹30,362 Cr
P/E Ratio	21.56x	144.46x
P/B Ratio	5.12x	6.23x
EPS	₹116.56	₹13.1
Book Value	₹491.29	₹304
Dividend Yield	0.48%	0%

Growth

Metric	LUPIN	WOCKPHARMA
Revenue Growth (TTM YoY)	31.9%	26%
EPS Growth (TTM YoY)	89%	0%
Qtr Sales Growth	31.9%	29.9%
Qtr Profit Growth	101%	688%

Profitability & Leverage

Metric	LUPIN	WOCKPHARMA
ROE	29.1%	6.11%
ROCE	30.3%	7.55%
Net Margin	17.65%	3.3%
Operating Margin	31.5%	19.3%
Debt to Equity	0.29x	0.45x

Shareholding

As of Mar 2026 • change vs previous quarter

Metric	LUPIN	WOCKPHARMA
Promoter Holding	46.57%▼ 0.04 pp	49.08%
FII Holding	21.71%▲ 0.22 pp	7.09%▲ 0.1 pp
DII Holding	25.32%▼ 0.26 pp	10.96%▲ 0.41 pp
Public Holding	6.11%▲ 0.08 pp	32.83%▼ 0.52 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Lupin Limited and Wockhardt Ltd.

Related Comparisons

Infosys vs TCS HDFC Bank vs ICICI Bank Axis Bank vs Kotak Mahindra Bank HCL Technologies vs Wipro Hindustan Unilever vs ITC Maruti Suzuki vs Tata Motors

Browse all stock comparisons →

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.